ALEXEY MARGOLIN

Profile

First Name

: ALEXEY

Middle Name

:

Last Name

: MARGOLIN

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER, DIRECTOR

ALNARA PHARMACEUTICALS INC

RICHARD H. ALDRICH, LEE BRETTMAN, ASHLEY DOMBKOWSKI, ROBERT GALLOTTO, ROBERT TEPPER, JAMES N. TOPPER, CHRISTOPH H. WESTPHAL

EXECUTIVE OFFICER, DIRECTOR

ALLENA PHARMACEUTICALS, INC.

AXEL BOLTE, LOUIS BRENNER, LOUIS BRENNER, M.D., ALLENE DIAZ, MARK FITZPATRICK, RICHARD D. KATZ, M.D., STEPHEN KRAUS, ANN C. MILLER, GINO SANTINI, ROBERT TEPPER, JAMES TOPPER

DIRECTOR

TODD CREECH, STEVE DUBIN, ERIC FIRST, ROBERT GALLOTTO, JAMES GAMGORT, GARHENG KONG, ANASTASIOS KONIDARIS, TASOS KONIDARIS, STEPHEN KRAUS, STEPHEN KRAUSS, JEREMY LACK, DANIEL ORLANDO, MARTIN PAZ, WILLIAM SCHEINLER, DANIEL TASSE, JAMES TOPPER

DIRECTOR

ALCRESTA THERAPEUTICS, INC.

TODD CREECH, STEVE DUBIN, ERIC FIRST, ROBERT GALLOTTO, JAMES GAMGORT, GARHENG KONG, ANASTASIOS KONIDARIS, TASOS KONIDARIS, STEPHEN KRAUS, STEPHEN KRAUSS, JEREMY LACK, DANIEL ORLANDO, MARTIN PAZ, WILLIAM SCHEINLER, DANIEL TASSE, JAMES TOPPER

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

PHARMACEUTICALS

BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]

DECLINE TO DISCLOSE

2022-05-04

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2020-02-28

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2019-01-14

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2017-09-15

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2016-03-22

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2016-03-22

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2015-11-25

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2014-10-29

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2010-01-25